Antibiotic shows promise for treating fragile X syndrome

04/10/2013 | Disability Scoop

Children with fragile X syndrome who received minocycline had modest improvements in anxiety levels and mood-related behaviors compared with a placebo group, researchers report in the Journal of Developmental and Behavioral Pediatrics. Some patients responded better to the medication than others, and researchers are looking for predictive biomarkers.

View Full Article in:

Disability Scoop

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR